Increase in CRP | 16.4 | 5.3 (3.4–8.3) | <0.001 | 49.5 | 84.5 | 7.6 |
Increased oxygen requirement or ventilatory support | 9.9 | 7.7 (5.0–12.0) | <0.001 | 43.4 | 91.0 | 11.0 |
Increase in apnoeic or bradycardic episodes | 8.5 | 6.5 (4.1–10.3) | <0.001 | 35.4 | 92.2 | 10.5 |
Hypotension | 6.5 | 3.6 (2.2–6.0) | <0.001 | 19.2 | 93.9 | 7.5 |
Glucose intolerance | 12.0 | 5.1 (3.3–7.8) | <0.001 | 39.4 | 88.7 | 8.2 |
Impaired peripheral perfusion | 6.8 | 8.5 (5.4–13.2) | <0.001 | 35.4 | 93.9 | 13.0 |
Lethargy | 6.7 | 7.9 (4.9–12.7) | <0.001 | 33.3 | 94.0 | 12.6 |
Temperature instability | 9.6 | 3.7 (2.3–6.0) | <0.001 | 27.3 | 90.9 | 7.1 |
Ileus/feed intolerance | 11.3 | 4.4 (2.8–6.8) | <0.001 | 34.3 | 89.3 | 7.6 |
Jaundice | 5.2 | 0.8 (0.3–2.2) | 0.6 | 96.0 | 5.2 | 2.5 |
Fall in urine output | 1.2 | 3.7 (1.2–11.2) | 0.02 | 4.0 | 98.9 | 8.5 |
Base deficit >−10 mmol/l | 4.9 | 7.0 (4.3–11.5) | <0.001 | 24.2 | 95.6 | 12.5 |
Anticonvulsant therapy | 0.7 | 1.5 (0.1–19.2) | 0.8 | 1.0 | 99.3 | 3.7 |